Jeong Uk Lim
Overview
Explore the profile of Jeong Uk Lim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
652
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lim J, Jung J, Kim Y, Kim C, Lee S, Park D, et al.
Biomedicines
. 2025 Feb;
13(2).
PMID: 40002883
Tyrosine kinase inhibitors (TKIs) have transformed the treatment of epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer. However, treatment resistance remains a major challenge in clinical practice. The tumor...
2.
Kim K, Kim K, Kang H, Shin A, Kim S, Park C, et al.
Ther Adv Med Oncol
. 2025 Feb;
17:17588359251316200.
PMID: 39926259
Background And Objectives: This study aimed to compare the efficacy of the second-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) alectinib and brigatinib in the treatment of advanced non-small-cell...
3.
Lee E, Lee S, Seong Y, Ku B, Cho H, Kim K, et al.
Transl Lung Cancer Res
. 2025 Jan;
13(12):3741-3763.
PMID: 39830742
Lung cancer is a malignant tumor with high incidence and mortality rates in both men and women worldwide. Although anticancer drugs are prescribed to treat lung cancer patients, individual responses...
4.
Yoo J, Lee Y, Park Y, Lee J, Choi J, Lee H, et al.
Tuberc Respir Dis (Seoul)
. 2024 Dec;
PMID: 39659117
A significant portion of newly diagnosed lung cancer cases occur in populations exposed to air pollution. The World Health Organization has identified air pollution as a human carcinogen, prompting many...
5.
Kim S, Rhee C, Jo Y, Lim J, Kim S, Yoo J, et al.
Sci Rep
. 2024 Nov;
14(1):29502.
PMID: 39604437
Previous studies suggest associations between the risk of developing chronic obstructive pulmonary disease (COPD) and adiponectin/leptin (ALR) and apolipoprotein B/A1 (APOR) ratios. This longitudinal observational study, using data from the...
6.
Hur J, Rhee C, Yoon H, Park C, Lim J, An T, et al.
J Inflamm (Lond)
. 2024 Nov;
21(1):42.
PMID: 39487493
Background: Air pollution, notably particulate matter (PM), significantly impacts chronic respiratory disease such chronic obstructive pulmonary disease (COPD). Although asthma-COPD overlap (ACO), considered one of the COPD etiotype, is associated...
7.
Lim J, Kim B, Han K, Lim J
Korean J Intern Med
. 2024 Oct;
PMID: 39434606
Background/aims: This study aimed to evaluate the impact of steatotic liver disease severity on the cumulative incidence of lung cancer utilizing data from the Korea National Health Insurance Service (NHIS)....
8.
Lim J, Kang H, Yeo C, Kim J, Kim S, Kim J, et al.
Ther Adv Med Oncol
. 2024 Oct;
16:17588359241281480.
PMID: 39371616
Background: Many patients with lung cancer have underlying chronic lung diseases. We assume that baseline lung functions might also affect the prognosis of non-small cell lung cancer (NSCLC) patients receiving...
9.
Hong H, Choi S, Jeon Y, Kim T, Kim S, An T, et al.
Infect Chemother
. 2024 Oct;
56(3):378-385.
PMID: 39370123
Background: Although patients with lymphoma appear particularly vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the clinical evolution of coronavirus disease 2019 (COVID-19) in a patient with lymphoid...
10.
Lim J, Kang H, Moon M, Yeo C, Sa Y, Kim T, et al.
Transl Lung Cancer Res
. 2024 Aug;
13(7):1463-1480.
PMID: 39118882
Background: Recent evidences showed that resection of lung tumor post-targeted therapy has shown progression-free survival (PFS) benefits in initially unresectable patients. The aim of this study is to evaluate pathologic...